Company news

Arecor Therapeutics PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Arecor Appoints Interim Chief Financial Officer

November 18, 2024

Interim Results for six months ended 30 June 2024

September 26, 2024

Arecor presents positive AT278 data at EASD

September 11, 2024

Arecor announces AT278 presentation at EASD 2024

September 3, 2024

Result of General Meeting and Total Voting Rights

August 8, 2024

Posting of Circular and General Meeting

July 23, 2024

Result of WRAP Retail Offer

July 23, 2024

Result of Placing and Subscription

July 19, 2024

WRAP Retail Offer to raise up to £1 million

July 19, 2024

Proposed Placing and Subscription

July 19, 2024

Trading and Funding Update

June 10, 2024

Posting of 2023 Annual Report and Notice of AGM

May 31, 2024

Arecor to host company and KOL webinar today

May 21, 2024

Positive headline results for AT278 clinical trial

May 20, 2024

Final results for 2023

May 16, 2024

Arecor and Medtronic Diabetes collaboration

May 9, 2024

Publication of Full Year Financial Results delayed

May 3, 2024

Notice of results

April 29, 2024

Board change

April 23, 2024

Arecor and TRx Biosciences research collaboration

March 12, 2024

Arecor announces launch of Ogluo® in Netherlands

February 29, 2024

Year End Trading Update

February 1, 2024

Arecor announces update on INBRX-101

January 23, 2024

Arecor granted key European patent

January 18, 2024

Expansion of specialty hospital collaboration

January 8, 2024

Appointment of SVP for Tetris Pharma Ltd

January 3, 2024

Agreement with global medical products company

December 4, 2023

Arecor Continues Collaboration with Lilly

November 29, 2023

Product with Arestat technology launched in Europe

November 17, 2023

Inhibrx milestone triggers payment to Arecor

November 2, 2023

Exercise of rollover options & Total Voting Rights

November 1, 2023

Progress of Phase I clinical study of AT278

October 2, 2023

Arecor on Investor Meet Company Platform

September 15, 2023

Interim Results for six months ended 30 June 2023

September 14, 2023

Arecor: positive Hikma FDA pre-IND meeting

September 7, 2023

Tetris pharma announces agreement with Goodlife

September 4, 2023

Collaboration With Top 10 Global Pharma

August 17, 2023

Arecor Business Update

July 20, 2023

Additional Agreement with Leading Biopharma

July 5, 2023

Arecor granted key patents in Europe and China

June 27, 2023

Arecor presents positive data for AT247 at ADA

June 26, 2023

AGM Statement

June 9, 2023

Director/PDMR Shareholding

May 24, 2023

Tetris pharma launches Ogluo® in Denmark & Norway

May 15, 2023

Arecor 2022 annual report and notice of AGM

May 4, 2023

Arecor Granted Key U.S Patent

April 26, 2023

Unaudited Preliminary Results for 2022

April 20, 2023

Arecor Appoints Chief Business Officer

April 5, 2023

First patient dosed in AT278 clinical trial

March 22, 2023

Price Monitoring Extension

March 13, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 11 decks. Every deck is listed under its year.